317 related articles for article (PubMed ID: 7844555)
1. Leukaemogenesis by the delta Mo + SV Moloney murine leukaemia virus (M-MuLV) variant in E mu pim-1 transgenic mice: high frequency of recombination with a solo endogenous M-MuLV LTR in vivo.
Suchman EL; Pattengale PK; Fan H
J Gen Virol; 1995 Feb; 76 ( Pt 2)():347-56. PubMed ID: 7844555
[TBL] [Abstract][Full Text] [Related]
2. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
Hanecak R; Pattengale PK; Fan H
J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
[TBL] [Abstract][Full Text] [Related]
3. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
Brightman BK; Farmer C; Fan H
J Virol; 1993 Dec; 67(12):7140-8. PubMed ID: 8230436
[TBL] [Abstract][Full Text] [Related]
4. Leukemogenicity of Moloney murine leukemia viruses carrying polyoma enhancer sequences in the long terminal repeat is dependent on the nature of the inserted polyoma sequences.
Fan H; Chute H; Chao E; Pattengale PK
Virology; 1988 Sep; 166(1):58-65. PubMed ID: 2842957
[TBL] [Abstract][Full Text] [Related]
5. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
Fan H; Mittal S; Chute H; Chao E; Pattengale PK
J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
[TBL] [Abstract][Full Text] [Related]
6. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
Brightman BK; Okimoto M; Kulkarni V; Lander JK; Fan H
Virology; 1998 Mar; 242(1):60-7. PubMed ID: 9501051
[TBL] [Abstract][Full Text] [Related]
7. Recombinant mink cell focus-inducing virus and long terminal repeat alterations accompany the increased leukemogenicity of the Mo+PyF101 variant of Moloney murine leukemia virus after intraperitoneal inoculation.
Belli B; Patel A; Fan H
J Virol; 1995 Feb; 69(2):1037-43. PubMed ID: 7815481
[TBL] [Abstract][Full Text] [Related]
8. Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.
Feuer G; Fan H
J Virol; 1990 Dec; 64(12):6130-40. PubMed ID: 2173784
[TBL] [Abstract][Full Text] [Related]
9. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
10. Tumorigenic potential of a recombinant retrovirus containing sequences from Moloney murine leukemia virus and feline leukemia virus.
Starkey CR; Lobelle-Rich PA; Granger SW; Brightman BK; Fan H; Levy LS
J Virol; 1998 Feb; 72(2):1078-84. PubMed ID: 9445002
[TBL] [Abstract][Full Text] [Related]
11. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.
Johnson C; Lobelle-Rich PA; Puetter A; Levy LS
J Virol; 2005 Jan; 79(1):57-66. PubMed ID: 15596801
[TBL] [Abstract][Full Text] [Related]
12. The leukemogenic potential of an enhancer variant of Moloney murine leukemia virus varies with the route of inoculation.
Belli B; Fan H
J Virol; 1994 Nov; 68(11):6883-9. PubMed ID: 7933068
[TBL] [Abstract][Full Text] [Related]
13. Chromatin structure of recombinant Moloney murine leukemia virus proviral DNAs that contain tax-responsive sequences from human T-cell lymphotropic virus type II in the presence and absence of tax.
Kitado H; Fan H
J Virol; 1989 Jul; 63(7):3072-9. PubMed ID: 2786092
[TBL] [Abstract][Full Text] [Related]
14. Regions of the Moloney murine leukemia virus genome specifically related to induction of promonocytic tumors.
Wolff L; Koller R
J Virol; 1990 Jan; 64(1):155-60. PubMed ID: 2403439
[TBL] [Abstract][Full Text] [Related]
15. Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus.
Hanecak R; Pattengale PK; Fan H
J Virol; 1991 Oct; 65(10):5357-63. PubMed ID: 1895389
[TBL] [Abstract][Full Text] [Related]
16. A multistep process of leukemogenesis in Moloney murine leukemia virus-infected mice that is modulated by retroviral pseudotyping and interference.
Lavignon M; Evans L
J Virol; 1996 Jun; 70(6):3852-62. PubMed ID: 8648721
[TBL] [Abstract][Full Text] [Related]
17. A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice.
Atencio IA; Belli B; Hobbs M; Cheng SF; Villarreal LP; Fan H
Virology; 1995 Oct; 212(2):356-66. PubMed ID: 7571405
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow depletion by 89Sr complements a preleukemic defect in a long terminal repeat variant of Moloney murine leukemia virus.
Li QX; Fan H
J Virol; 1991 Aug; 65(8):4442-8. PubMed ID: 1649340
[TBL] [Abstract][Full Text] [Related]
19. E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.
Möröy T; Verbeek S; Ma A; Achacoso P; Berns A; Alt F
Oncogene; 1991 Nov; 6(11):1941-8. PubMed ID: 1658705
[TBL] [Abstract][Full Text] [Related]
20. Differential disease restriction of Moloney and Friend murine leukemia viruses by the mouse Rmcf gene is governed by the viral long terminal repeat.
Brightman BK; Li QX; Trepp DJ; Fan H
J Exp Med; 1991 Aug; 174(2):389-96. PubMed ID: 1856627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
